S. 339: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
The bill known as the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act proposes amendments to the Social Security Act to allow for Medicare coverage of multi-cancer early detection screening tests. Here are the key points of the bill:
Coverage for Multi-Cancer Screening Tests
The bill adds provisions to Medicare that will cover specific multi-cancer early detection screening tests starting from January 1, 2028. These tests are aimed at detecting multiple types of cancer across different organs at once, and they must meet certain regulatory criteria set by the Food and Drug Administration (FDA).
Definition of Multi-Cancer Early Detection Screening Tests
A "multi-cancer early detection screening test" is defined in the bill as follows:
- Tests must be approved or cleared by the FDA.
- Tests may involve genomic sequencing of blood samples or similar biological materials.
- Tests must be deemed reasonable and necessary for early illness detection by the Secretary of Health and Human Services.
National Coverage Determination Process
The Secretary of Health and Human Services is required to use a specific process to make national coverage determinations for these new tests, ensuring that they meet the necessary criteria for coverage.
Payment Structure and Standards
The bill outlines a payment structure for the multi-cancer early detection screening tests:
- For tests provided before January 1, 2031, the payment would equal the current payment amount for certain existing cancer screening tests.
- For tests provided on or after January 1, 2031, the payment will be based on specific calculations that may take current test payments into account.
Limitations on Payment
There are specific limitations on payment for these tests:
- Payments will not be made if the individual has reached a certain age or if they received a similar test within the past 11 months.
- Starting from 2028, the age limit is set at 68 years, increasing by one year each subsequent year.
Coverage for Other Cancer Screening Tests
The bill makes it clear that receiving a multi-cancer early detection screening test does not eliminate coverage for other individual cancer screening tests like breast, cervical, colorectal, lung, or prostate cancer tests.
Conforming Amendments
The legislation includes various conforming amendments to other sections of the Social Security Act to align the current provisions with the newly introduced coverage for multi-cancer early detection screening tests.
Effective Date
The proposed changes to Medicare coverage begin with a planned implementation date of January 1, 2028.
Relevant Companies
- ILMN - Illumina, Inc.: A company that specializes in genomic sequencing technology, which could see an increase in business due to the demand for multi-cancer early detection screening tests.
- NVTA - Invitae Corporation: Focuses on genetic testing and could benefit from an increase in usage of genomic tests covered under this bill.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
69 bill sponsors
-
TrackMike Crapo
Sponsor
-
TrackAngela Alsobrooks
Co-Sponsor
-
TrackTammy Baldwin
Co-Sponsor
-
TrackJim Banks
Co-Sponsor
-
TrackJohn Barrasso
Co-Sponsor
-
TrackMichael F. Bennet
Co-Sponsor
-
TrackRichard Blumenthal
Co-Sponsor
-
TrackLisa Blunt Rochester
Co-Sponsor
-
TrackCory A. Booker
Co-Sponsor
-
TrackJohn Boozman
Co-Sponsor
-
TrackKatie Boyd Britt
Co-Sponsor
-
TrackTed Budd
Co-Sponsor
-
TrackMaria Cantwell
Co-Sponsor
-
TrackShelley Moore Capito
Co-Sponsor
-
TrackBill Cassidy
Co-Sponsor
-
TrackSusan M. Collins
Co-Sponsor
-
TrackChristopher A. Coons
Co-Sponsor
-
TrackJohn Cornyn
Co-Sponsor
-
TrackCatherine Cortez Masto
Co-Sponsor
-
TrackKevin Cramer
Co-Sponsor
-
TrackSteve Daines
Co-Sponsor
-
TrackJohn Fetterman
Co-Sponsor
-
TrackRuben Gallego
Co-Sponsor
-
TrackKirsten E. Gillibrand
Co-Sponsor
-
TrackLindsey Graham
Co-Sponsor
-
TrackChuck Grassley
Co-Sponsor
-
TrackMargaret Wood Hassan
Co-Sponsor
-
TrackMartin Heinrich
Co-Sponsor
-
TrackJohn W. Hickenlooper
Co-Sponsor
-
TrackMazie K. Hirono
Co-Sponsor
-
TrackJon Husted
Co-Sponsor
-
TrackCindy Hyde-Smith
Co-Sponsor
-
TrackJames C. Justice
Co-Sponsor
-
TrackMark Kelly
Co-Sponsor
-
TrackJohn Kennedy
Co-Sponsor
-
TrackAndy Kim
Co-Sponsor
-
TrackAngus S. King Jr.
Co-Sponsor
-
TrackAmy Klobuchar
Co-Sponsor
-
TrackJames Lankford
Co-Sponsor
-
TrackRoger Marshall
Co-Sponsor
-
TrackMitch McConnell
Co-Sponsor
-
TrackDavid McCormick
Co-Sponsor
-
TrackJeff Merkley
Co-Sponsor
-
TrackBernie Moreno
Co-Sponsor
-
TrackMarkwayne Mullin
Co-Sponsor
-
TrackLisa Murkowski
Co-Sponsor
-
TrackPatty Murray
Co-Sponsor
-
TrackJon Ossoff
Co-Sponsor
-
TrackAlex Padilla
Co-Sponsor
-
TrackGary C. Peters
Co-Sponsor
-
TrackJack Reed
Co-Sponsor
-
TrackJames E. Risch
Co-Sponsor
-
TrackJacky Rosen
Co-Sponsor
-
TrackMike Rounds
Co-Sponsor
-
TrackAdam B. Schiff
Co-Sponsor
-
TrackRick Scott
Co-Sponsor
-
TrackTim Scott
Co-Sponsor
-
TrackJeanne Shaheen
Co-Sponsor
-
TrackElissa Slotkin
Co-Sponsor
-
TrackTina Smith
Co-Sponsor
-
TrackDan Sullivan
Co-Sponsor
-
TrackThom Tillis
Co-Sponsor
-
TrackChris Van Hollen
Co-Sponsor
-
TrackMark R. Warner
Co-Sponsor
-
TrackPeter Welch
Co-Sponsor
-
TrackSheldon Whitehouse
Co-Sponsor
-
TrackRoger F. Wicker
Co-Sponsor
-
TrackRon Wyden
Co-Sponsor
-
TrackTodd Young
Co-Sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Jan. 30, 2025 | Introduced in Senate |
| Jan. 30, 2025 | Read twice and referred to the Committee on Finance. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
